Preparing for the renaissance: treating breast cancer during the COVID-19 pandemic and planning for a safe re-emergence to routine surgical care within a universal health care system.
作者信息
Berger-Richardson D, Ko G, Hong N J Look
机构信息
Department of Surgery, University of Toronto, Toronto, ON.
Division of Surgical Oncology, Sunnybrook Health Sciences Centre, Toronto, ON.
出版信息
Curr Oncol. 2020 Jun;27(3):163-168. doi: 10.3747/co.27.6699. Epub 2020 Jun 1.
Abstract
摘要
相似文献
1
Preparing for the renaissance: treating breast cancer during the COVID-19 pandemic and planning for a safe re-emergence to routine surgical care within a universal health care system.
Curr Oncol. 2020 Jun;27(3):163-168. doi: 10.3747/co.27.6699. Epub 2020 Jun 1.
2
Will Jordan be closer to UHC after the COVID-19 pandemic?
J Glob Health. 2020 Dec;10(2):020360. doi: 10.7189/jogh.10.020360.
3
Health coverage and what Kenya can learn from the COVID-19 pandemic.
J Glob Health. 2020 Dec;10(2):020362. doi: 10.7189/jogh.10.020362.
4
Editorial debate: Challenges we oncologists, working within a universal healthcare system, have to face in these hard times.
ESMO Open. 2020 May;5(3):e000800. doi: 10.1136/esmoopen-2020-000800.
5
The need to strengthen Primary Health Care in Brazil in the context of the COVID-19 pandemic.
Braz Oral Res. 2020;34:e047. doi: 10.1590/1807-3107bor-2020.vol34.0047. Epub 2020 May 11.
6
Breast unit Efficacy with the relocation of the surgical breast team during the COVID-19 pandemic.
Breast J. 2020 Aug;26(8):1613-1614. doi: 10.1111/tbj.13934. Epub 2020 Jun 16.
7
[Surgical care during the new coronavirus (Covid-19) pandemic].
Khirurgiia (Mosk). 2020(9):92-101. doi: 10.17116/hirurgia202009192.
8
Ethical Challenges in Advance Care Planning During the COVID-19 Pandemic.
Am J Bioeth. 2020 Jul;20(7):202-204. doi: 10.1080/15265161.2020.1779855.
9
Re: Primary Care Practice Finances in the United States amid the COVID-19 Pandemic.
J Urol. 2020 Dec;204(6):1370-1371. doi: 10.1097/JU.0000000000001278.01. Epub 2020 Sep 22.
10
Response to: (Marinelli and Lawrence, 2020).
J Hum Lact. 2020 Aug;36(3):541. doi: 10.1177/0890334420923364. Epub 2020 Apr 23.
引用本文的文献
1
Impact of the COVID-19 pandemic on breast cancer surgeries in a Canadian population.
Breast Cancer Res Treat. 2025 Feb;210(1):147-156. doi: 10.1007/s10549-024-07547-9. Epub 2024 Nov 15.
2
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications.
Breast Cancer (Dove Med Press). 2023 Jan 27;15:51-89. doi: 10.2147/BCTT.S390296. eCollection 2023.
3
When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA.
Langenbecks Arch Surg. 2022 Jun;407(4):1315-1332. doi: 10.1007/s00423-022-02495-8. Epub 2022 Mar 21.
4
Analysis of Facilitators and Barriers to the Delivery of Routine Care during the COVID-19 Global Pandemic: A Systematic Review.
Healthcare (Basel). 2021 May 1;9(5):528. doi: 10.3390/healthcare9050528.
5
Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic.
Curr Oncol. 2021 Mar 24;28(2):1338-1347. doi: 10.3390/curroncol28020127.
6
Impact of the COVID-19 pandemic on cancer diagnosis, treatment and research in African health systems: a review of current evidence and contextual perspectives.
Ecancermedicalscience. 2021 Jan 14;15:1170. doi: 10.3332/ecancer.2021.1170. eCollection 2021.
7
Triple-Negative Breast Cancer and the COVID-19 Pandemic: Clinical Management Perspectives and Potential Consequences of Infection.
Cancers (Basel). 2021 Jan 15;13(2):296. doi: 10.3390/cancers13020296.
本文引用的文献
1
International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic.
Clin Oncol (R Coll Radiol). 2020 May;32(5):279-281. doi: 10.1016/j.clon.2020.03.006.
2
Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).
J Clin Oncol. 2020 Apr 20;38(12):1284-1292. doi: 10.1200/JCO.19.00510. Epub 2020 Mar 3.
3
Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer.
Ann Surg Oncol. 2020 Feb;27(2):386-396. doi: 10.1245/s10434-019-07844-4. Epub 2019 Sep 27.
4
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
BMJ Open. 2019 Mar 12;9(3):e026797. doi: 10.1136/bmjopen-2018-026797.
5
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5.
6
Timing and Delays in Breast Cancer Evaluation and Treatment.
Ann Surg Oncol. 2018 Oct;25(10):2829-2838. doi: 10.1245/s10434-018-6615-2. Epub 2018 Jul 2.
7
Neoadjuvant Radiotherapy: Changing the Treatment Sequence to Allow Immediate Free Autologous Breast Reconstruction.
J Reconstr Microsurg. 2018 Oct;34(8):624-631. doi: 10.1055/s-0038-1660871. Epub 2018 Jun 16.
8
Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients.
Breast Care (Basel). 2017 Dec;12(6):401-408. doi: 10.1159/000480492. Epub 2017 Dec 3.
9
Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma .
Cancer Prev Res (Phila). 2017 Aug;10(8):434-441. doi: 10.1158/1940-6207.CAPR-17-0100. Epub 2017 Jun 13.
10
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
N Engl J Med. 2017 Jun 1;376(22):2147-2159. doi: 10.1056/NEJMoa1612645.
Zotero 插件